Target intelligence / Profile preview

Campylobacter coli surface receptors

Molecular classification
Outer membrane protein, Adhesin, Bacterial surface antigen, Porin, Lipoprotein
01

Overview

Campylobacter coli surface receptors are a heterogeneous group of proteins and glycoconjugates located on the outer membrane of the Gram-negative bacterium Campylobacter coli. These molecules serve as the primary interface for interaction with the host environment and are essential for the pathogen's virulence and survival. Key receptors include adhesins such as CadF (Campylobacter adhesion to fibronectin) and FlpA (Fibronectin-like protein A), which mediate binding to host extracellular matrix components to facilitate colonization (Konkel et al., 1997; Flanagan et al., 2009). Additionally, the Major Outer Membrane Protein (MOMP) acts as a porin for nutrient acquisition, while other surface components like PEB1 are involved in both transport and adherence (Bolton, 2015). These receptors are significant targets for the development of vaccines and phage therapies aimed at preventing campylobacteriosis, a leading cause of bacterial gastroenteritis worldwide (Meunier et al., 2016). However, the high degree of phase variation and genetic diversity among C. coli surface proteins presents a challenge for broad-spectrum therapeutic efficacy and may contribute to immune evasion. Furthermore, certain surface structures, such as lipooligosaccharides, can exhibit molecular mimicry with host tissues, potentially triggering autoimmune conditions like Guillain-Barré syndrome (Yuki et al., 2004).

Other names
Campylobacter coli surface proteinsC. coli outer membrane proteinsC. coli adhesinsC. coli surface antigens
02

Mechanism of action

Inhibition of bacterial attachment to host intestinal cells, neutralization of virulence factors by specific antibodies, and targeted bacterial lysis via phage binding to surface receptors.

03

Biological functions

Bacterial adhesionHost cell invasionNutrient transportMotilityImmune evasion
04

Disease associations

InfectionGastroenteritisCampylobacteriosisGuillain-Barré syndrome
05

Safety considerations

Risk of autoimmune cross-reactivity (molecular mimicry)High antigenic variation leading to vaccine escapePotential for phage resistance
06

Interacting drugs

Experimental Campylobacter vaccines

2 more in the full profile.

07

Biomarkers

Anti-CadF antibodiesC. coli surface antigensMOMP (Major Outer Membrane Protein)

Beyond the preview

Go deeper on Campylobacter coli surface receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Campylobacter coli surface receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call